Pay in 4 interest-free payments of $5.30 Learn more
Ships within 48 hours · Estimated delivery Sep 27 - Oct 2
Many people say, "I caught the same cold again." Fortunately, that's usually not how the immune system works
Based on Phase 2 safety data (Jastreboff et al., NEJM 2023), common early adverse effects reported include: Nausea (the most frequently reported adverse effect) Vomiting Diarrhoea or constipation Reduced appetite Mild fatigue or dizziness These effects are consistent with the GLP-1 receptor agonist class and typically reflect the gut's adaptation to altered gastric emptying and hormonal signalling
Clinical studies show that patients lose an average of 21% of their starting weight after 72 weeks of treatment
A new Pew Research Center survey examines Americans attitudes about a new class of drugs being used for weight loss, including Ozempic and Wegovy
